Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: NDA 3, ANDA 1.
| Dosage form | NDCs |
|---|---|
| capsule | 2 |
| capsule, extended release | 1 |
| tablet | 1 |
| Route | NDCs |
|---|---|
| oral | 4 |
| Labeller name on the listing | NDCs |
|---|---|
| acertis pharmaceuticals, llc | 3 |
| acertis pharmaceuticals, llc | 1 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Levorphanol Tartrate | Levorphanol Tartrate | tablet, oral | 72989-417ANDA |
| PHENDIMETRAZINE TARTRATE | PHENDIMETRAZINE TARTRATE | capsule, extended release, oral | 72989-409NDA |
| Prometrium | Progesterone | capsule, oral | 72989-372NDA |
| Prometrium | Progesterone | capsule, oral | 72989-373NDA |
Compare
Other companies listing progesterone
- Catalent Pharma Solutions Inc.22 sites · 261 NDC
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Ferring Pharmaceuticals Inc.9 sites · 17 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Hikma Pharmaceuticals USA Inc.4 sites · 763 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Deseret Laboratories Incorporated2 sites · 858 NDC
- MEDISCA Inc.2 sites · 305 NDC
Enquiry
Common questions
- Is Acertis Pharmaceuticals, LLC FDA approved?
- Acertis Pharmaceuticals, LLC holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Acertis Pharmaceuticals, LLC make?
- 4 products are listed under Acertis Pharmaceuticals, LLC in the openFDA NDC Directory, most often as capsule; capsule, extended release; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.